TREATMENT OF OBESITY USING NON-DAILY ADMINISTRATION OF 6-O-(4-DIMETHYLAMINOETHOXY) CINNAMOYL FUMAGILLOL

• 1. 使用非每天施用的6-0-(4-二甲基氨基乙氧基)肉桂酰烟曲霉醇治疗肥胖症 [P] . 中国专利： CN103379905A . 2013-10-30
• 2. 6-O-(4-二甲基氨基乙氧基)肉桂酰烟曲霉醇草酸盐的多晶型盐及其制备和使用方法 [P] . 中国专利： CN104350046B . 2016.11.30
• 3. Treatment of Obesity Using Non-Daily Administration of 6-O-(4-Dimethylaminoethoxy) Cinnamoyl Fumagillol [P] . 美国专利： US2018221328A1 . 2018-08-09

  机译： 非每日服用6-O-（4-二甲基氨基乙氧基）肉桂酰基富马吉洛治疗肥胖

• 4. Treatment of obesity using non-daily administration of 6-O-(4-dimethylaminoethoxy) cinnamoyl fumagillol [P] . 美国专利： US9000035B2 . 2015-04-07

  机译： 使用非每日服用6-O-（4-二甲基氨基乙氧基）肉桂酰基烟曲霉酚治疗肥胖

• 5. Treatment of obesity using non-daily administration of 6-O-(4-dimethylaminoethoxy) cinnamoyl fumagillol [P] . 美国专利： US9173865B2 . 2015-11-03

  机译： 使用非每日服用6-O-（4-二甲基氨基乙氧基）肉桂酰基烟曲霉酚治疗肥胖

• 1. Could sport be part of pediatric obesity prevention and treatment? Expert conclusions from the 28th European Childhood Obesity Group Congress [J] . Susanne Ring-Dimitriou, Marie-Laure Frelut, Eva Erhardt, 运动与健康科学（英文版） . 2019,第004期
• 2. Baicalein 6-O-β-D-glucopyranuronoside is a main metabolite in the plasma after oral administration of baicalin, a flavone glucuronide of scutellariae radix, to rats [J] . Akao T., Sato K., He J.-X., Biological & pharmaceutical bulletin . 2013,第5期
• 3. Oral administration of Rehmannia glutinosa extract for obesity treatment via adiposity and fatty acid binding protein expression in obese rats [J] . Mi-Young Park, Hyun Jung Lee, Da Hyeon Choi, Toxicology and Environmental Health Sciences . 2017,第5期
• 4. Counseling alone or in combination with nicotine replacement therapy for treatment of black non-daily smokers: a randomized trial [J] . Addiction . 2020,第8期
• 5. From Body Dissatisfaction to Obesity: How Virtual Reality May Improve Obesity Prevention and Treatment in Adolescents [C] . Giuseppe RIVA, Andrea GAGGIOLI, Antonios DAKANALIS Medicine Meets Virtual Reality . 2013
• 6. The Treatment Effects of Dietary Oils on Diet-Induced Obesity, Lipidemia, and Insulin Resistance in Skeletal Muscle Tissue of Obese Prone Rats [D] . Dunthorne, Karin 2011
• 7. A Randomized Clinical Trial of Counseling and Nicotine Replacement Therapy for Treatment of African American Non-Daily Smokers: Design Accrual and Baseline Characteristics [O] . Nicole L. Nollen, Lisa Sanderson Cox, Matthew S. Mayo, -1
• 8. Efficacy and Tolerability of non-daily Statin Administration: A Systematic Review of Literature [O] . Cindy Park, Quang Le 2019

• 1. Veterans health administration hepatitis B testing and treatment with anti-CD20 antibody administration [J] . Christine M Hunt ,Lauren A Beste ,Elliott Lowy . 世界胃肠病学杂志：英文版 . 2016,第19期
• 2. Long-Term Treatment with an Herbal Formula MCC Ameliorates Obesity-Associated Metabolic Dysfunction in High Fat Diet-Induced Obese Mice: A Comparative Study among MCC and Various Combinations of Its Constituents [J] . Pou Kuan Leong ,Hoi Yan Leung ,Hoi Shan Wong . 中医（英文） . 2014,第1期
• 3. TREATMENT OF OBESITY SIMPLEX WITH KANG LING ANTI-OBESITY MIXTURE [J] . 奚彩昆 ,钱佩琼 ,蒋红玉 . 中医杂志：英文版 . 1990,第2期
• 4. Optimization of Exenatide plus Detemir Treatment for Morbid Obese Patients with Insulin Dependent Diabetes Resistant to Conventional Treatment. Effect of Exenatide on Patients with Mellitus Diabetes Type 2 [J] . Alfonso Lopez Ruiz ,Maria Angeles Nunez Sanchez ,Noelia Victoria Garcia-Talavera Espin . 药理与制药（英文） . 2014,第4期
• 5. 4-乙氧基肉桂酸对蘑菇酪氨酸酶抑制作用机制研究 [C] . 崔沂 ,喻枫 ,王会芳 . 全国农业生物化学与分子生物学第十四届学术研讨会 . 2015
• 6. 医药中间体N-(4-氨基-2-乙氧基-苯基)乙酰胺的合成与表征 [A] . 郭勇伟 . 2010